Competitive (Reversible) Inhibition
The drug pirlindole is a classic example of a reversible inhibitor. Structurally, it is a chemical analogue of the natural neurotransmitter serotonin. Due to this similarity, the drug molecule is able to bind to the active site of the enzyme.
The biochemical essence of this process lies in direct competition. The enzyme (denoted as E) has a choice: it can bind either with the natural substrate (S) to form the ES complex, which then dissociates into free enzyme and product (P), or with the inhibitor molecule (I) to form the EI complex.
- Normal reaction scheme: $E + S \rightleftarrows ES \rightarrow E + P$
- In the presence of pirlindole: $E + I \rightleftarrows EI$
A key feature of this type of interaction is the formation of a weak bond. This means that the blockade is temporary. As soon as the concentration of the drug in the body begins to decrease (as it is naturally eliminated), the enzyme-inhibitor complex dissociates. Enzyme activity is fully restored without the need to synthesize new protein molecules.
Irreversible Inhibition
A completely different mechanism of action is demonstrated by nialamide. Unlike structural substrate analogues, it causes irreversible inhibition of enzymatic activity.
When an enzyme molecule (E) encounters an inhibitor molecule (I), a chemical reaction occurs, resulting in the formation of strong covalent bonds with functional groups located in the active site.
- Inactivation scheme: $E + I \rightarrow E-I$
This reaction represents covalent modification. The resulting EI complex is stable and no longer dissociates under any conditions. The enzyme is permanently knocked out of function because its active site is physically blocked and structurally altered.
Comparison of Therapeutic Effect Duration
The difference in biochemical mechanisms directly determines how long the clinical effect of these drugs persists in patients.
Pirlindole is characterized by a relatively short duration of action. Since the inhibition is reversible, the drug's effect depends directly on its current tissue concentration. As soon as the drug is cleared from the body, the enzymes are released and immediately resume their function.
Nialamide exerts a much more prolonged effect on the body. Because the enzyme molecules are irreversibly inactivated, simply clearing the drug substance from the bloodstream does not return the system to its initial state. Activity will not recover until cells synthesize brand-new enzyme molecules. This physiological process of protein biosynthesis takes significant time and can take up to two weeks. Throughout this entire period, the therapeutic effect persists despite the absence of the drug itself in the body.